The number of non-human primates (NHPs) used as laboratory animals is relatively small, compared with the numbers of other species -2,186 in Great Britain in 2012, compared with 273,046 rats and 3,049,956 mice. 1 Nevertheless, it is vital that such use is kept under close scrutiny, in terms of both scientific justification and ethical acceptability, for two main reasons. First, their cognitive abilities and complex behavioural and social demands approach those of humans, so there is great concern about the application to them of procedures which would be considered unethical if applied to humans. A second, and related, reason is that, if we can't get it right for NHPs, other types of laboratory animals stand no chance at all.
The number of non-human primates (NHPs) used as laboratory animals is relatively small, compared with the numbers of other species -2,186 in Great Britain in 2012, compared with 273,046 rats and 3,049,956 mice. 1 Nevertheless, it is vital that such use is kept under close scrutiny, in terms of both scientific justification and ethical acceptability, for two main reasons. First, their cognitive abilities and complex behavioural and social demands approach those of humans, so there is great concern about the application to them of procedures which would be considered unethical if applied to humans. A second, and related, reason is that, if we can't get it right for NHPs, other types of laboratory animals stand no chance at all.
Over the years, many and wide-ranging opinions have been expressed, on the use of NHPs in laboratories, and there have been a plethora of reports from many kinds of organisations. There have been many calls for greater transparency on why and how NHPs are used and for the progressive phasing out of such use, but there continues to be insistence that their use is essential in fundamental research and safety testing -indeed, there was a 22% increase in the number of procedures involving NHPs in British laboratories in 2012.
This issue of ATLA contains what some will see as yet another report, but this one, by Sauer, Phillips, Reed, Schmit and Jennings, 2 is outstanding, original and important, since it deals with the ethical review of projects involving NHPs, funded by the European Commission (Commission) in Frame work Programme (FP) 7, as Directive 2010/ 63/EU was about to take over from Directive 86/ 609/EEC.
Bearing in mind the Commission's commitment to greater openness, Sauer et al. set out to: review and evaluate the information available in the public domain on NHP use in FP7 projects; determine how these projects were assessed from an ethical point of view; and consider whether any changes are required to the ethical review process for future FPs. Their main approach to the collection of information was to consult the Framework Programme Community Research and Development Information Service (CORDIS; http://cordis. europa.eu/fp7/projects_en.html). This revealed a total of 70 FP7 projects which might involve the use of NHPs, but only 41 of them either explicitly involved their use or were judged to be very likely to do so, and another six were considered, since NHP use was possible. Project-specific websites were available for 22 of the 47 projects, which offered another source of information.
Sadly, Sauer et al. were forced to conclude that the information available on CORDIS was limited, that "the titles and abstracts of the projects are often very vague, and there are no key words describing the animal species used or the methodologies applied". Also, "even where the abstracts are explicit about the use of primates, very few gave any indication of the procedures that the animals would be subjected to, and none gave any estimates of the numbers involved". Links to the homepages of the participating institutions provided little further information, and Sauer et al. were concerned that "public access to the outcome of EU-funded research is limited by the fact that not all projects have published their results in open access journals".
All that is chillingly-reminiscent of what was said in the 1990 report of an RSPCA/FRAME survey of NHP use in Britain from 1984 to 1988: 3 "It was impossible to tell from many of the published papers precisely what had been done to the animals, why they had been used, how many animals had been involved, where they had come from, what post-operative care was given, how they had been generally cared for, or what eventually happened to them." Living up to the promise of greater openness in the application of Directive 2010/63/EU will be very demanding, given the conclusions of an analysis of publicly-available information on NHP use in EU FP7-funded projects
The FP7-funded research involved neuroscience (21 projects; with €41.2 of EU funding), infectious diseases (12; €56.5 million), evolutionary biology (6; €4.2 million), or a variety of other purposes (8; €23 million). Consultation of FP7-related publications and CORDIS revealed little or no information about the housing of the animals, their sources, animal-welfare considerations or the Three Rs, and no information about severity or the use of humane endpoints. A detailed discussion is provided of five example projects.
Grant-holders were consulted about the ethical review process. In general, they accepted that the review process was meaningful and necessary, but some of them feared that the new Directive would lead to tougher requirements, while others referred to delays in project acceptance or to the work required in compiling the necessary ethics documentation.
Sauer et al. conclude their report with three sets of conclusions and 15 recommendations, on public accountability, on the ethics review of EU-funded projects involving NHPs in the light of Directive 2010/63/EU, and on strengthening the inherent value of the EU-based ethics review process. These conclusions are positive, and they deserve careful consideration, while the recommendations are well-intentioned, and they should be implemented without delay. Meanwhile, the Commission should lie low on transparency until ways of delivering it have been worked out, and Parliamentarians in Strasbourg and elsewhere should shun mere rhetoric and seek some genuine progress toward the aspirations of many of their constituents. Actions speak louder than words.
All that having been said, there is an unavoidable sting in the tail. 
